Effective non pharmacological treatment of menopausal symptoms in BC patients. Acupuncture for hot flashes in hormone receptor-positive breast cancer: A pooled analysis of individual patient dat… pubmed.ncbi.nlm.nih.gov/38924035/

Perfect your breast clinical examination skills! 😀Comparison of Clinical Breast Exam to Breast MRI Surveillance in Patients Following Nipple-Sparing Mastectomy pubmed.ncbi.nlm.nih.gov/38609794/

Importance of not only losing bone, but also bone microarchitecture when receiving estrogen suppressive therapy pubmed.ncbi.nlm.nih.gov/38954783/

New Special Article in press: ESMO Recommendations on clinical reporting of genomics test results for solid cancers Joris van de Haar Rodrigo Dienstmann_MD_MBA FabriceAndre Ben Westphalen Joaquin Mateo doi.org/10.1016/j.anno…

Happy to share our published review: Hormone receptor-positive early breast cancer in young women: A comprehensive review - Cancer Treatment Reviews cancertreatmentreviews.com/article/S0305-… Tremendous team effort Isabel Garcia Fructuoso Olga Martínez-Sáez Francesco Schettini, MD PhD 🇮🇹🇪🇸🇪🇺 César y j Sanchez Maria Vidal

Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study pubmed.ncbi.nlm.nih.gov/39019916/ Very nice paper on the impact of concomitant drugs in pts treated with abemaciclib using the DRUG-PIN tool

Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients… pubmed.ncbi.nlm.nih.gov/39028916/ This is really intriguing

HER2: a remarkable story of precision oncology. Check this wonderful Nature review on targeting HER2 beyond breast. 👉Important to remember: now that we have an agnostic anti-HER2 drug approved (T-DXd), every adv cancer patient should get HER2 testing! nature.com/articles/s4157…

I'm full of joy for having been interviewed by my friend and greatest scientist Khalid El Bairi for the The ASCO Post ! #Globaloncology #ONCOLLEGE #cancer 🗺️

Race-Based Diagnosis, Part 3: ITT Episode 35: New England Journal of Medicine: Vol 391, No 5 nejm.org/doi/full/10.10… Very nice reading in this week NEJM

The experience of breast cancer can be psychologically traumatic long beyond initial diagnosis. In this piece, led by Cristiane D Bergerot, we review the emotional complexities faced by survivors & the psychological interventions designed to promote resilience. apm.amegroups.org/article/view/1…

Stronger adjuvant endocrine therpy is better in low BCI risk women, but makes no difference in high risk pubmed.ncbi.nlm.nih.gov/39145953/

Proud to share our latest work: the MOZART study. We explored the actionable genomic landscape (505 genes + TMB) in >200 metastatic solid tumors, checked correlations between PDL1 expression and genomic alterations and ESCAT % per tumor type👇🏻 rb.gy/x734r3 A brief 🧵

CTS-5 not useful in HER2+/HR+ patients pubmed.ncbi.nlm.nih.gov/39191270/

Proud of joining this terrific group of oncologists and friends to contribute as ESMO Ambassador for #ESMO24

Wonderful presentation by Joana Ribeiro on approaches to post preop tx for eTNBC #ESMO24 OncoAlert

Proud to be part of this academic effort !